Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05063305 · ClinicalTrials.gov registry record · NA
Probiotics, Immunity, Stress, and QofL
A NA study, sponsored by Loma Linda University.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT05063305 is a NA study that has completed, run by Loma Linda University. The registered enrollment target is 100 participants.
The verdict
NCT05063305, a NA study, has completed, sponsored by Loma Linda University.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The purpose of this graduate student research study is to evaluate the efficacy of a multi-strain probiotic and investigate if sex differences influence the role of probiotics on stress and immunity biomarkers.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Probiotic
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2021-09-27 |
| Est. Completion | 2022-01-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05063305
The ClinicalTrials.gov registry entry for NCT05063305 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loma Linda University, which has 237 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT05063305 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05063305 about?
NCT05063305 is a clinical study titled "Probiotics, Immunity, Stress, and QofL". The purpose of this graduate student research study is to evaluate the efficacy of a multi-strain probiotic and investigate if sex differences influence the role of probiotics on stress and immunity biomarkers.
What is the current status of trial NCT05063305?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2021-09-27. Estimated completion is 2022-01-27.
What interventions are being tested in trial NCT05063305?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Probiotic (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05063305?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.